HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Detecting neurodegenerative diseases before symptoms appear
Latest Videos

Detecting neurodegenerative diseases before symptoms appear

6:03

Russ Lebovitz, CEO of Amprion, discusses the company’s partnership with Mayo Clinic Laboratories to expand access to its test that detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy.

Read More
Read Less

Latest Videos - Similar Videos View more in Latest Videos

3:20

Asset management is the key to survival

No matter how big or small a healthcare organization is, a full understanding of its assets is critical to cyberdefense, says Luta Security's Katie Moussouris as she shares insights on national infrastructure security.

Asset management is the key to survival
No matter how big or small a healthcare organization is, a full understanding of its assets is critical to cyberdefense, says Luta Security's Katie Moussouris as she shares insights on national infrastructure security.
3:20
7:00

AI can address clinician burden and burnout, but care must be taken

Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.

AI can address clinician burden and burnout, but care must be taken
Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.
7:00
3:58

Fighting cancer and genetic disease with 'living medicines'

Boro Dropuliç, executive director of Caring Cross, explains how gene and cell therapies "reprogram" the patient's own cells to stop the progression of certain cancers and genetic conditions, with remission rates of up to 92%.

Fighting cancer and genetic disease with 'living medicines'
Boro Dropuliç, executive director of Caring Cross, explains how gene and cell therapies "reprogram" the patient's own cells to stop the progression of certain cancers and genetic conditions, with remission rates of up to 92%.
3:58